- Guggenheim cut Biogen Inc BIIB price target from $410 to $325. Biogen shares closed at $321.17 on Thursday.
- Berenberg cut the price target for Qualys Inc QLYS from $96 to $82. Qualys shares closed at $84.34 on Thursday.
- B. Riley FBR lifted the price target on Acacia Communications, Inc. ACIA from $45 to $50.50. Acacia Communications shares closed at $47.17 on Thursday.
- UBS cut the price target for Kraft Heinz Co KHC from $55 to $39. Kraft Heinz shares closed at $48.18 on Thursday.
- Guggenheim lowered the price target for Regeneron Pharmaceuticals Inc REGN from $466 to $425. Regeneron Pharmaceuticals shares closed at $418.62 on Thursday.
- RBC Capital lowered the price target for Immune Design Corp IMDZ from $9 to $6. Immune Design shares closed at $5.82 on Thursday.
- Jefferies raised Citigroup Inc C price target from $64 to $73. Citigroup shares closed at $64.32 on Thursday.
- Sidoti & Co. cut the price target for Anika Therapeutics Inc ANIK from $56 to $41. Anika Therapeutics shares closed at $40.49 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in